Signant Finance One Limited and Bracket Intermediate Holding Corp.
Clinical-trial technology company serving pharmaceutical sponsors and contract research organizations (CROs). Signant's platform spans eCOA (electronic clinical outcome assessment - capturing patient/clinician-reported trial data on devices), eConsent, patient engagement, IRT (interactive response technology for randomization and drug supply), and endpoint data quality. The two names in the filing are co-borrower/holding entities of one company: 'Bracket' is a predecessor brand that merged with CRF Health to form the business now branded Signant Health.
Company profile compiled from public sources (company filings, rating-agency reports, and press releases) — distinct from the SEC Schedule-of-Investments pricing data below.
Lenders
Signant Finance One Limited and Bracket Intermediate Holding Corp. is held by 2 BDC lenders in our parsed SEC filings: AGTC, ARCC.
Cross-lender loan pricing
Each row is one debt tranche at the BDC’s most recent filing that holds this borrower, widest spread first. Mark is the position’s fair value as a percent of par (100 = par). Spread is shown in basis points over the benchmark in the Rate column, normalized from each filing’s as-reported units — rows quoting different benchmarks are still not directly comparable. Compare like-for-like: a second-lien tranche, a different vintage, or an older filing should price wider even when the credit view is identical — check the Type and Filing columns before reading a gap as disagreement. Source: SEC EDGAR (public).
| BDC | Type | Rate | Cash spread (bps) | Mark (% of par) | Fair Value | Maturity | Filing |
|---|---|---|---|---|---|---|---|
| AGTC | 1L Sr Secured | SOFR | 500 | 98.0 | $1M | 2031-10 | 2026-08-07 |
| AGTC | 1L Sr Secured | SOFR | 500 | 98.0 | $22M | 2031-10 | 2026-08-07 |
| ARCC | 1L Sr Secured | SOFR | 500 | 100.0 | $100K | 2031-10 | 2026-07-29 |
| ARCC | 1L Sr Secured | SOFR | 500 | 90.9 | $1M | 2031-10 | 2026-07-29 |
| ARCC | 1L Sr Secured | SOFR | 500 | 98.1 | $62M | 2031-10 | 2026-07-29 |
Marks reflect each BDC’s own fair-value estimates as reported to the SEC, not traded prices. Private-credit loans are predominantly Level 3 under ASC 820 — valued from unobservable inputs and determined in good faith by each BDC’s board, so figures are estimates as of the filing date and are not directly comparable across managers. Informational only; not investment advice or a valuation.
Ownership & deal activity
Verified headlines that signal an acquisition, merger, buyout, sponsor change, refinancing, or restructuring involving Signant Finance One Limited and Bracket Intermediate Holding Corp.. A mention is not confirmation of a completed deal — verify against the linked source. Source: Google News.
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- US: Genstar-backed Signant Health acquires Ametris from Archimed
- Signant Health Engages CNS Community at ASCP 2026 Following Acquisition of Ametris
- Signant Health Acquires Ametris to Combine Wearable Data and eCOA Technology
- Signant Health Acquires Ametris to Expand Clinical Trial Data Platform
- Signant Health: Acquisition Of Ametris Creates End-To-End eCOA And Digital Outcome Measures Platform
- Signant Health Acquires Ametris to Create an End-to-End eCOA and Digital Outcome Measures Platform
Headlines mentioning Signant Finance One Limited and Bracket Intermediate Holding Corp.
Public headlines that name Signant Finance One Limited and Bracket Intermediate Holding Corp., matched by company name and shown most-recent first. A mention is not an endorsement, a rating, or investment advice — verify anything material against the original source. Source: Google News.
- Signant Health Global eCOA Library Surpasses 9,000 Translations, Accelerating Global Study Startup
- Signant Health Launches Forecasting & Planning Assist™, Putting the Power of Agentic AI in the Hands of Clinical Supply Experts
- Signant Health Number of Employees 2026 | Employee Count & Headcount Data
- Signant Health Accelerates RTSM Study Builds and Amendments, Combining Deep Domain Expertise with AI Capability
- Signant Health Oy
- Signant Health Acquires Ametris To Create An End-To-End eCOA And Wearables Platform
- US: Genstar-backed Signant Health acquires Ametris from Archimed
- Signant Health Engages CNS Community at ASCP 2026 Following Acquisition of Ametris
Reading this table
When two business development companies lend to the same borrower, comparing how each marks the loan is a starting question, not a verdict. In plain English: a wider spread (e.g. S+575 vs S+525) or a lower mark (e.g. 96 vs 100 cents on the dollar) can mean that lender is pricing in more risk — but marks can also differ for reasons other than a credit view: a different tranche (second lien should price wider than first lien on the same company), a different vintage or entry point, an older filing date, or each manager’s own fair-value methodology. Compare like-for-like — check the Type and Filing columns before reading a gap as disagreement. Each row is one debt position at one BDC’s most recent filing. Source: SEC EDGAR Schedule of Investments (public).
Want to read these numbers like an analyst? Free Oxford Ledge lessons: reading a BDC’s Schedule of Investments, key credit metrics, and the Five Cs of credit analysis.